Expectations of protectionist policies by the US under the new administration and the strengthening dollar have put emerging markets stocks, bonds and currencies under pressure. A spike in US treasury yields over the past couple of days has led to aggressive unwinding of carry-trade positions in developing markets. Yields on 10-year US treasuries rose a further 15 bps yesterday to 2.15%. Yields on 30-year bonds are at 2.94% after climbing 23 bps over the past couple of days. MSCI emerging markets equity index dropped 0.5% yesterday after falling 2.5% the day before. MSCI emerging markets currency index fell 1.0% yesterday after a 0.7% drop the day before. S&P futures are down 0.3%, Euro Stoxx is down 0.4%, Nikkei 225 is 0.3% higher while China’s CSI is up 0.8%. The dollar index is flat today after rising some 1% over the past couple of days. The pound sterling has been the main beneficiary of the volatility, gaining 0.7% today to 1.264. Bloomberg commodity index is 0.1% higher while gold price is down 0.2%. Copper is up 5.5% today gaining over 15% since the beginning of the week.
Oil prices declined amid evidence of higher OPEC output. Iran (which is seeking an exemption from OPEC’s deal on production curbs) has increased output by 0.21 mn bbl in October. Brent prices are down 1.5% on the day at $45.1/bbl.
Russia and CIS area developments and market colour
The rouble weakened 0.2% to 65.8 against the dollar. OFZ yields widened by up to 5 bps in the short end and up to 15 bps in the longer part of the curve, extending yesterday’s sell-off. The OFZ yield curve flattened and is now upward sloping. Yields on CIS Eurobonds have been boosted by the sell-off in US and European government debt. Russia and Kazakhstan longer-term sovereign Eurobond yields are about 15-17 bps and 27-29 bps wider today respectively after widening about 13-15 bps yesterday. Ukraine Eurobonds yields are 12-13 bps wider today.
Eurochem published weak Q3 2016 results. Eurochem’s EBITDA in Q3 fell 47% YoY to $230mn from $438mn a year earlier. Over the first 9 months, EBITDA contracted 33% YoY from $1.2bn in 2015 to $0.81bn in 2016. EBITDA margin declined to 25% in Q3 2016 from 35% in the previous year. Total revenue in Q3 2016 was down 6% YoY to $1.05bn on the back of lower prices despite the 12% growth in sales volumes. Net debt totaled $3.35bn as of 30 September. Earlier the company announced plans to raise a perpetual interest-free loan in the amount of up to $1.5bn from its main shareholder (Melnichenko) in Q4 2016.
For more information on the research, please click here.
Norvik Banka Research
+44 207 259 8854
This report is prepared by Norvik Banka UK Limited, of 46-48 Grosvenor Gardens, London, SW1W 0EB, United Kingdom (hereinafter referred to as the Company) as a marketing communication for information purposes only. Neither the information nor any opinion contained in this report (notwithstanding the source) is intended to be, or should be construed as an offer, a recommendation, an advice or an invitation to make an offer, to buy or sell any financial instrument. Information contained in this report constitutes neither investment nor tax advice and it does not take into account the specific investment objectives, risk appetite and financial situation of anyone who may receive this report. Investors should seek their own advice regarding the appropriateness of investing in any financial instrument discussed in this report and carefully evaluate the risks and eventual losses that are related to the investment services and its compliance with their investment goals.
Investors should note that any income derived from investments in financial instruments may fluctuate and that the price or value of securities and investments may rise or fall. Accordingly, investors may lose their investment or receive back less than originally invested. Past performance and income is not a guide to future performance and income. Foreign currency exchange rates may adversely affect the value, price or income of any security or related investment mentioned in this report. Investing in the Russian or CIS economies and securities involves a high degree of risk and requires appropriate knowledge and experience.
The information contained in this report have been obtained from such public sources what are believed to be reliable, but no representation or warranty is made by the Company with regard to accuracy. Therefore the information contained herein is subject to change without prior notice.
This report should not be viewed as the only source of information, and neither the Company, nor the companies within the NORVIK group and/or any affiliates or employees thereof accept any responsibility or liability whatsoever for any direct or indirect damage arising out of or in any way connected with the use of information contained herein, nor for its authenticity.
This report may not be distributed, copied, reproduced or changed without prior written consent from the Company. Further information, which for the avoidance of doubt cannot be treated as the recommendations and/or advice either, may be obtained from the Company upon request.
This report has not been prepared on the basis of the requirements of regulatory provisions promoting independence of investment research and is not subject to the prohibition from making transactions before disseminating investment research.
Norvik Banka Research is a Trading Name of Norvik Banka UK Ltd, which is Authorised and Regulated by the Financial Conduct Authority, FRN: 681329. Registered in England and Wales with number 08940522. Registered Office: 46/48 Grosvenor Gardens 1st Floor, London, SW1W 0EB.
The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the recipient, you are hereby notified that any disclosure, copying, distribution or taking action in relation of the contents of this information is strictly prohibited and may be unlawful.
This email has been scanned for viruses and malware, and may have been automatically archived by Mimecast Ltd, an innovator in Software as a Service (SaaS) for business. Providing a safer and more useful place for your human generated data. Specializing in; Security, archiving and compliance. To find out more Click Here.